Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
MYnd Analytics Inc
MYND | US
0.43
USD0.01
1.62%
MYND | US
About MYnd Analytics Inc
Sector
Healthcare
Industry
Diagnostics & Research
Earnings date
31/12/2021
As of date
06/03/2026
Close
0.43
Open
0.42
High
0.43
Low
0.42
View Less
MYND | US
Risk
62.7
Sharpe
-0.77
Luna's Score
31/100
Recommendation
Sell
Luna says (MYND | US)
What's Working
Value Stock (Price to Book < 3)
What's not Working
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
34.6%1 month
62.7%3 months
73.9%6 months
79.7%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.82
Debt to equity
1.17
Debt to assets
0.28
Ent. to EBITDA
-4.87
Ent. to rev.
0.24
PEG
-
Other Fundamentals
EBITDA
-9.70M
MarketCap
19.49M
MarketCap(USD)
19.49M
Div. yield
-
Op. margin
-6.48
Erngs. growth
-
Rev. growth
-25.40
Ret. on equity
-135.61
Short ratio
1.51
Short perc.
0.75
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.17
Range1M
0.17
Range3M
0.26
Volumes: Market Activity
Rel. volume
0.14
Price X volume
390.19
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -4.87 | - | Cheaper |
| Ent. to Revenue | 0.24 | - | Cheaper |
| PE Ratio | - | 40.09 | - |
| Price to Book | 0.82 | 77.50 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 73.87 | - | Riskier |
| Debt to Equity | 1.17 | -14.36 | Expensive |
| Debt to Assets | 0.28 | 0.34 | Par |
| Market Cap | 19.49M | - | Emerging |
